• Browse
• Meine Registrierung (Login)
• Registrierung (frei)

Pharmaceutical News

• Sustainability Is Watchword For Industry, Say Speakers At World Congress On Industrial B ...
  Tue, 29 April 2008
  Sustainability was on the minds of many of today's speakers at the World Congress on Industrial Biotechnology and Bioprocessing, an annual conference attracting more than 1200 scientists, business leaders, and government officials that began in full today in Chicago. John Heissenbuttel of Heissenbuttel Natural Resource Consu ...
• Global Health, Sustainable Agriculture And International Business Issues Focus Of 2008 B ...
  Tue, 29 April 2008
  Global issues such as intellectual property protections, follow-on biologics/biosimilars, international networking for research and development of neglected diseases and sustainable agriculture in developing countries will all be primary focus areas of the 2008 BIO International Convention.
• State RFS Waivers Could Derail Advanced Biofuels
  Tue, 29 April 2008
  Granting Texas' or other states' requests for a federal waiver of the Renewable Fuel Standard (RFS) would not reduce food prices but could hinder or delay advanced biofuel research, the Biotechnology Industry Organization (BIO) said. BIO opposes Texas Gov. Rick Perry's request to the U.S. Environmental Protection Agency for ...
• Purdue Expert Says U.S. Has Low Risk Of Receiving Contaminated Drugs
  Tue, 29 April 2008
  A Purdue University expert says distribution of contaminated pharmaceuticals in the United States is a concern, but an individual's risk of receiving such a drug is very low. Tragic events such as the recent deaths and illnesses caused by contaminated heparin are alarming, but are extremely rare, says Stephen R. Byrn, the Ch ...
• GE Healthcare Completes Acquisition Of Whatman Plc
  Tue, 29 April 2008
  GE Healthcare, a unit of General Electric Company (NYSE:GE) announced that it has completed the acquisition of Whatman plc, a global supplier of filtration products and technologies. The acquisition expands GE Healthcare's offering for life science research and biopharmaceutical manufacturing, a key area of growth for the c ...
• BIO Celebrates National DNA Day
  Tue, 29 April 2008
  Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement today in observance of National DNA Day: Today we celebrate National DNA Day to commemorate the discovery of DNA's double helix in 1953 and the completion of the Human Genome Project in April 2003.
• Editorial, Opinion Piece Address Whether FDA Approval Of Medications Should Exempt Compa ...
  Mon, 28 April 2008
  USA Today on Friday published an editorial and an opinion piece that addressed whether FDA approval of medications should protect pharmaceutical companies from product liability lawsuits filed in state courts. The Supreme Court this year will hear a case that could decide the issue.
• Deadly Dose: Heparin Expert Helps Uncover Source Of Lethal Contamination
  Sat, 26 April 2008
  The mysterious death of patients around the world following a routine dosage of the common blood thinner, heparin, sent researchers on a frantic search to uncover what could make the standard drug so toxic. A researcher at Rensselaer Polytechnic Institute was among a small group of scientists with the expertise and the high- ...
• Newark Star-Ledger Examines Effect Of Wal-Mart Generic Drug Discount Program On Pharmace ...
  Fri, 25 April 2008
  The Newark Star-Ledger on Tuesday examined how analysts say the overall impact of Wal-Mart Stores' generic prescription drug program on the pharmaceutical industry has been relatively small (Cohen/Fitzgerald, Newark Star-Ledger, 4/22).
• Threat To Pharmaceutical Industry Support For University Research
  Thu, 24 April 2008
  The pharmaceutical industry has extensive collaborative research links with the UK university science base, but there are growing signs that it is under threat, according to data published by the Association of the British Pharmaceutical Industry (ABPI). The ABPI figures, gained from a survey of 11 major UK-based pharmaceuti ...